Herbs (Global Traditional) · Traditional Chinese Medicine
Acanthopanax senticosus
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Acanthopanax senticosus contains bioactive eleutherosides that modulate the hypothalamic-pituitary-adrenal axis to reduce stress and improve cardiovascular function. Clinical studies demonstrate significant reductions in systolic blood pressure and improvements in endothelial function through eNOS activation.
Acanthopanax senticosus (Siberian ginseng or Eleutherococcus senticosus) is a shrub native to Russia, China, Korea, and Japan, belonging to the Araliaceae family. The bioactive parts including roots, stems, leaves, and fruits are typically extracted using ethanol or water-based methods. This adaptogenic herb is rich in lignans, phenolics, and polysaccharides.
A 12-week randomized, double-blind, placebo-controlled trial (n=76 completers; PMID: 32765813) found that 500 mg/day of fruit extract significantly reduced systolic blood pressure and arterial stiffness in adults with cardiovascular risk factors. Another study (PMID: 19452124) in postmenopausal Korean women showed benefits for bone turnover markers. Most other evidence remains at the preclinical level, with no large-scale RCTs or meta-analyses available for other indications.
Clinically studied dosages include fruit extract at 500 mg/day (taken as 2 capsules twice daily), which showed efficacy for blood pressure and arterial stiffness over 12 weeks. Higher doses of 1,000 mg/day did not show significant benefits in the same trial. Root extract has been studied for bone health, though specific dosages were not detailed. Consult a healthcare provider before starting any new supplement.
Acanthopanax senticosus (Siberian Ginseng/Eleuthero) contains negligible macronutrients in typical therapeutic doses (dried root extract 300–1200 mg/day). Key bioactive compounds include: Eleutherosides (0.6–0.9% in standardized extracts) — primarily Eleutheroside B (syringin, ~0.1–0.5 mg/g dry root) and Eleutheroside E (syringaresinol diglucoside, ~0.1–0.3 mg/g dry root), which are the primary marker compounds for standardization and largely responsible for adaptogenic and vascular effects including eNOS activation. Polysaccharides (Eleutherans A–G, ~3–5% of dry root weight) contribute to immunomodulatory activity with moderate oral bioavailability. Ciwujianosides (triterpenoid saponins, ~0.2–0.8 mg/g) support anti-inflammatory pathways. Lignans including (-)-sesamin and syringaresinol (~0.05–0.2 mg/g) contribute to antioxidant activity. Phenylpropanoids including caffeic acid derivatives (~0.3–0.8 mg/g) support vascular endothelial function. Isofraxidin (a coumarin, ~0.05–0.15 mg/g) has demonstrated CNS and cognitive-supportive activity. Chlorogenic acid (~0.1–0.4 mg/g) provides antioxidant support. Minerals present in root material include potassium (~8–12 mg/g dry weight), calcium (~3–6 mg/g), magnesium (~1–3 mg/g), and trace iron (~0.1–0.3 mg/g). Vitamin E (tocopherols, ~0.2–0.5 mg/g) and beta-carotene precursors are present at low levels in whole root. Dietary fiber comprises approximately 15–25% of dry root weight (primarily insoluble). Bioavailability notes: Eleutheroside B shows approximately 30–40% oral bioavailability with peak plasma concentration at ~1–2 hours post-ingestion; absorption is enhanced when taken with food. Polysaccharide bioavailability is limited (~10–20%) due to molecular size but partial fermentation by gut microbiota may enhance systemic effects. Standardized extracts (typically to 0.8% Eleutheroside B+E) provide more consistent bioactive delivery than whole root powder.
Acanthopanax senticosus contains eleutherosides B and E that activate endothelial nitric oxide synthase (eNOS), increasing nitric oxide production for vasodilation. The eleutherosides also modulate cortisol release through hypothalamic-pituitary-adrenal axis regulation, reducing stress-induced cardiovascular strain. These compounds enhance calcium channel function and improve arterial compliance through direct effects on vascular smooth muscle.
A randomized controlled trial with 76 adults showed Acanthopanax senticosus reduced systolic blood pressure by 7.7 mmHg and improved arterial stiffness in borderline hypertensive patients over 8 weeks. Human trials demonstrate enhanced endothelial function through measurable eNOS activation, providing moderate evidence for cardiovascular benefits. Additional studies suggest support for bone turnover markers, though this research remains preliminary. The cardiovascular evidence is considered moderate quality due to limited study replication and relatively small sample sizes.
Acanthopanax senticosus is generally well-tolerated with mild side effects including occasional insomnia, headache, and gastrointestinal upset at higher doses. It may interact with anticoagulant medications like warfarin due to potential effects on platelet aggregation and bleeding time. The supplement should be avoided by individuals taking antihypertensive medications without medical supervision due to additive blood pressure-lowering effects. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.
